INDIGO: Example of inappropriate crossover and why PFS cannot be the primary outcome in gliomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

INDIGO: Example of inappropriate crossover and why PFS cannot be the primary outcome in gliomas

Published:2024-06 Issue: Volume:40 Page:100476
ISSN:2213-5383
Container-title:Journal of Cancer Policy
language:en
Short-container-title:Journal of Cancer Policy

Author:

Zugman Miguel,Haslam Alyson,Prasad Vinay^ORCID

Funder

Arnold Ventures LLC

Publisher

Elsevier BV

Reference13 articles.

1. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial;van den Bent;Lancet,2016

2. Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma;Tabrizi;Radiother. Oncol.,2019

3. Vorasidenib in IDH1- or IDH2-mutant low-grade glioma;Bent;N. Engl. J. Med.,2023

4. When is crossover desirable in cancer drug trials and when is it problematic?;Haslam;Ann. Oncol.,2018

5. Post-progression treatment in cancer randomized trials: a cross-sectional study of trials leading to FDA approval and published trials between 2018 and 2020;Olivier;BMC Cancer,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP